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Abstract The misfolding of specific proteins is often
associated with their assembly into fibrillar aggregates,
commonly termed amyloid fibrils. Despite the many efforts
expended to characterize amyloid formation in vitro, there
is no deep knowledge about the environment (in which
aggregation occurs) as well as mechanism of this type of
protein aggregation. Alpha-chymotrypsin was recently
driven toward amyloid aggregation by the addition of
intermediate concentrations of trifluoroethanol. In the
present study, approaches such as turbidimetric, thermo-
dynamic, intrinsic fluorescence and quenching studies as
well as chemical modification have been successfully used
to elucidate the underlying role of hydrophobic interactions
(involved in early stages of amyloid formation) in a-chy-
motrypsin-based experimental system.
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Abbreviations
BSA Bovine serum albumin
DSC Differential Scanning Calorimetry
PSH Protein surface hydrophobicity
TFE 2,2,2-Trifluoroethanol
CR Congo red
ThT Thioflavin T
a-CD a-Cyclodextrin
TNBS 2,4,6-Trinitrobenzenesulfonic acid
ANS 1,8-Anilinonaphtalenesulfonate
BTEE N-Benzoyl-L-tyrosyl-ethyl ester
PMSF Phenyl methyl sulphonyl fluoride
1 Introduction
Protein aggregation and misfolding have gained great deal
of attention due to their undesirable consequences both in
vivo and in vitro [10, 53, 62]. Furthermore, protein mis-
folding followed by fibrillar aggregation is now well rec-
ognized to be a major contributing factor in a group of
pathologic states known as amyloid diseases [40, 55]. It is
estimated that *50% of the human diseases, including
cancer and degenerative diseases, are caused by folding
defects in a variety of organs and tissues [16]. One of the
holy grails in understanding the molecular mechanism of
protein fibrillogenesis lies in identifying, characterizing
and kinetically controlling the formation of the partially
folded aggregate species [25, 56]. Therefore, there is now a
strong motivation to elucidate the types of involved inter-
actions and characterize the conditions where the formation
of aggregation-prone species can be kinetically controlled
[42, 54]. Within the past 10 years, induction/inhibition of
partially folded aggregation-prone species as well as the
kinetic mechanism of amyloid-type aggregation by several
(disease and non-disease related) proteins has been fre-
quently investigated [22, 31, 36, 42, 45, 48]. Also, the
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